Safety and dose-finding study of activated protein C (drotrecogin alfa activated) as an anticoagulant in end-stage renal disease patients treated with hemodialysis

Authors

Ermira Brasha-Mitchell
Ashte Collins
Lindita Shehu
Michael G. Seneff, George Washington University
Samir S. Patel, George Washington University
Lakhmir S. Chawla, George Washington UniversityFollow

Document Type

Journal Article

Publication Date

6-26-2014

Journal

Blood Purification

Volume

Volume 37, Issue 3

Inclusive Pages

243-248

DOI

10.1159/000362154

APA Citation

Brasha-Mitchell, E., Collins, A., Shehu, L., Seneff, M.G., Patel, S.S. et al. (2014). Safety and dose-finding study of activated protein C (drotrecogin alfa activated) as an anticoagulant in end-stage renal disease patients treated with hemodialysis. Blood Purification, 37(3), 243-248.

Peer Reviewed

1